POPCaP Act of 2026

The POPCaP Act of 2026 establishes a precision oncology program within the Department of Veterans Affairs specifically for veterans diagnosed with prostate cancer. To deliver this care, the bill designates 21 existing VA medical centers across the country as provisional centers of excellence, requiring each to perform genetic sequencing, participate in clinical trials, and maintain specific staffing levels including oncologists and researchers. These centers will operate under a centralized leadership team that coordinates research activities, manages a national data registry, and ensures veterans have access to the latest biomarker-specific treatments. The legislation authorizes $15.5 million annually for fiscal years 2027 through 2029 to fund the program and mandates annual reports to Congress detailing patient outcomes and research progress.